Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,300
Closed -$109K 294
2025
Q3
$109K Hold
1,300
0.02% 284
2025
Q2
$103K Hold
1,300
0.02% 280
2025
Q1
$117K Hold
1,300
0.02% 274
2024
Q4
$129K Hold
1,300
0.02% 286
2024
Q3
$148K Buy
+1,300
New +$154K 0.03% 293

Other funds holding MRK

Insight Advisors's MRK Position: Q2 2026 in Review

Insight Advisors reduced its Merck (MRK) stake by 2.6% in Q2 2026, selling an estimated $60.3K and leaving 19,571 shares worth $2.51M. The position accounts for 0.44% of the portfolio, ranked #32.

Insight Advisors first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.07M in Q2 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Insight Advisors held 19,571 shares of Merck worth $2.51M as of Q2 2026.
  • Insight Advisors sold 515 Merck shares in Q2 2026, an estimated $60.3K.
  • Merck made up 0.44% of Insight Advisors's portfolio in Q2 2026, its #32 holding.
  • Insight Advisors first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Insight Advisors's Merck position peaked at $3.07M in Q2 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Insight Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.